Development of thrombosis in patients with SARS-CoV-2 infection

Authors

DOI:

https://doi.org/10.33448/rsd-v10i9.18246

Keywords:

Covid-19; Respiratory Syndrome; Coagulation; Thromboembolism.

Abstract

The pandemic caused by the SARS-CoV-2 coronavirus, in addition to possibly causing alveolar lung injury and acute respiratory failure, has a high prevalence of cardiovascular diseases, especially venous thromboembolism (VTE). The work aims to expose, through the analysis of scientific articles, the main complications of the development of thrombosis in patients infected with COVID-19. This is a literature review of a qualitative nature based on scientific production based on studies already published between the years 2019 to 2021. Some studies suggest that patients with COVID-19 may present a state of hypercoagulability, in which a state of hypercoagulability occurs. increased serum factor VIII, von Willebrand factor and fibrinogen levels. Hypercoagulability may influence the development of deep venous thrombosis of the lower limbs and/or pulmonary embolism in these patients. SARS-Cov-2 infection presents with a variety of complications, with frequent reports of cardiovascular problems and the presence of a prothrombotic state, caused by mechanisms that have not yet been fully elucidated. The evidence about COVID-19 and its interaction with the coagulation and platelet activation system is not yet fully understood.

References

Brandão, S. C. S., Godoi, E. T. A. M., Ramos, J. D. O. X., Melo, L. M. M. P. D., Dompieri, L. T., Brindeiro, D. F., & Sarinho, E. S. C. (2021). Papel do Endotélio na COVID-19 Grave. Arquivos Brasileiros de Cardiologia, 115, 1184-1189.

Brandão, S. C. S., Godoi, E. T. A. M., Ramos, J. D. O. X., Melo, L. M. M. P. D., & Sarinho, E. S. C. (2020). COVID-19 grave: entenda o papel da imunidade, do endotélio e da coagulação na prática clínica. Jornal Vascular Brasileiro, 19.

Carvalho, A. C. S., de Albuquerque Barros, L. S., Tenório, E. C. P. T., Lopes, T. P., Lopes, L. P., & da Cruz, C. M. (2020). Moduladores de coagulação alterados comprometem os pacientes infectados com COVID-19. Brazilian Journal of Health Review, 3(5).

Casella, I. B. (2020). Fisiopatologia da trombose associada à infecção pelo SARS-CoV-2. Jornal Vascular Brasileiro, 1677-7301.

Cunha, M. J. S., Pinto, C. A. V., Guerra, J. C. D. C., Tachibana, A., Portugal, M. F. C., Ferraz, L. J. R., & Wolosker, N. (2021). Incidence, diagnosis, treatment methods, and outcomes of clinically suspected venous thromboembolic disease in patients with COVID-19 in a quaternary hospital in Brazil. Jornal Vascular Brasileiro, 20.

de Borba Batschauer, A. P., & JOVITA, H. W. (2020). Hemostasia e COVID-19: fisiopatologia, exames laboratoriais e terapia anticoagulante. A Tempestade do Coronavírus, 52(2), 138-42.

De Freitas, A. L. G. C., Santos, M. S., & Dos Santos, J. A. B. (2021). Complicações vasculares pós covid-19. Brazilian Journal of Health Review, 4(3), 13090-13105.

Franco-López, Á., Escribano Poveda, J., & Vicente Gilabert, N. (2020). Tromboembolismo Pulmonar en los pacientes con COVID-19. Angiografía con tomografía computarizada: resultados preliminares. Journal of Negative and No Positive Results, 5(6), 616-630.

Nascimento, J. H. P., Gomes, B. F. D. O., Carmo, P. R. D., Petriz, J. L. F., Rizk, S. I., Costa, I. B. S. D. S., & Oliveira, G. M. M. D. (2020). COVID-19 e estado de hipercoagulabilidade: uma nova perspectiva terapêutica. Arquivos Brasileiros de Cardiologia, 114, 829-833.

Passos, H. D., Alves, M. C., Baumworcel, L., Vieira, J. P. C., Garcez, J. D. S., & Sousa, A. C. S. (2020). Infecção pelo SARS-Cov-2 e Tromboembolismo Pulmonar–Comportamento Pró-Trombótico da COVID-19. Arquivos Brasileiros de Cardiologia, 115, 142-145.

Roberto, G. A., Pacheco, L. R., Gusmão, M. R., & Gabriel, S. . A. (2020). COVID-19 e eventos tromboembólicos. Ulakes Journal Of Medicine, 1.

Rossi, F. H. (2020). Tromboembolismo venoso em pacientes COVID-19. Jornal Vascular Brasileiro, 19.

Soeiro, A. D. M., Leal, T. D. C. A. T., Pereira, M. D. P., Lima, E. G., Figueiredo, A. C. B. D. S., Petriz, J. L. F., & Serrano, C. V. (2020). Posicionamento sobre Uso de Antiplaquetários e Anticoagulantes nos Pacientes Infectados pelo Novo Coronavírus (COVID-19)–2020. Arquivos Brasileiros de Cardiologia, 115, 292-301.

Tiburi, R. G. B., Jucá, M. C. P., de Souza Sales, M., de Sousa, A. C. G., de Souza, T. N. L., da Silva, C. G. L., & Gadelha, M. D. S. V. (2021). Coagulopatia induzida pelo estado inflamatório da infecção pela Covid-19. Brazilian Journal of Health Review, 4(2), 8478-8501.

Downloads

Published

01/08/2021

How to Cite

MOTA, L. P.; SOUSA, M. V. A. de .; GONÇALVES, J. N. de A. .; LEAL, N. T. B. .; LEAL, L. B. .; NEGREIROS, A. L. B. .; SILVA, . D. H. da .; PENHA, A. A. G. da .; ALVES, N. S. .; FERREIRA, P. de F. .; LEAL, G. L. .; SOUSA, F. de A. da S. .; FREITAS, F. V. da S. .; SILVEIRA FILHO, E. R. da .; COSTA, J. D. da .; CARVALHO, M. M. de .; PEREIRA, M. G. de C. .; PEREIRA, S. A. .; SANTOS, J. M. F. dos . Development of thrombosis in patients with SARS-CoV-2 infection. Research, Society and Development, [S. l.], v. 10, n. 9, p. e52210918246, 2021. DOI: 10.33448/rsd-v10i9.18246. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/18246. Acesso em: 22 nov. 2024.

Issue

Vol. 10 No. 9

Section

Health Sciences

License

Copyright (c) 2021 Lennara Pereira Mota; Maria Vitalina Alves de Sousa; José Nilton de Araújo Gonçalves; Nahadja Tahaynara Barros Leal; Loisláyne Barros Leal; Ana Luiza Barbosa Negreiros; Danyele Holanda da Silva; Ana Alinne Gomes da Penha; Nágila Silva Alves; Priscila de Freitas Ferreira; Gersilane Lima Leal; Francisco de Assis da Silva Sousa; Francilene Vieira da Silva Freitas; Eudes Rufino da Silveira Filho; Jaqueline Dantas da Costa; Mayara Madeira de Carvalho; Maira Gislany de Castro Pereira; Stefânia Araújo Pereira; Joice Mara Ferreira dos Santos

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.